Loading...
Uploaded by ElsGlobalMedicalNews on Mar 15, 2011
Oral capecitabine shows considerable early promise for the secondary prevention of nonmelanoma skin cancers in solid organ transplant recipients and other immunosuppressed individuals, according to Dr. Paul Nghiem.
News & Politics
Standard YouTube License
Load more suggestions
All Comments